Nonoxidative pentose phosphate pathway regulates CD8<sup>+</sup> T cell immunity by maintaining NADPH homeostasis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41719332.
- Also identified by DOI 10.1073/pnas.2526325123 and PMC identifier 12933067.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
NADPH is essential for cellular biosynthesis and redox balance in CD8<sup>+</sup> T cells. Here, we demonstrate that the nonoxidative pentose phosphate pathway (non-oxPPP), mediated by transketolase (TKT) and transaldolase (TALDO1), is critical for CD8<sup>+</sup> T cell activation, proliferation, and memory formation by maintaining NADPH homeostasis. Metabolomic profiling and isotopic tracing revealed upregulated non-oxPPP flux in effector (T<sub>eff</sub>) and memory (T<sub>m</sub>) CD8<sup>+</sup> T cells, enabling a pentose cycle that amplifies NADPH yield and sustains metabolic fitness for T cell immunity. Genetic knockdown or pharmacological inhibition of <i>Tkt</i> or <i>Taldo1</i> impaired NADPH production, leading to ribose-5-phosphate (R5P) accumulation, oxidative stress, reduced lipid synthesis, mitochondrial dysfunction, and compromised T<sub>eff</sub> cell proliferation, cytokine production, and antitumor efficacy. Conversely, enhancing non-oxPPP activity promoted T<sub>m</sub> differentiation, persistence, and recall responses. Targeting the non-oxPPP represents a promising strategy to enhance cancer immunotherapy and vaccine efficacy by bolstering T cell effector and memory responses.
Medical subject headings
- Pentose Phosphate Pathway
- CD8-Positive T-Lymphocytes
- NADP